secwatch.observer — SEC 8-K summary
======================================

Issuer:     MINERVA SURGICAL INC (—)
CIK:        0001452965
Form:       8-K
Filed at:   2023-02-09T23:59:59+00:00
Accession:  0001193125-23-030400
Event type: other_material
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Minerva Surgical closes $30M private placement; Accelmed becomes controlling stockholder
--------------------------------------------------------------------------------

- Sold 146,627,565 shares at $0.2046/share for ~$30M gross proceeds; Piper Sandler sole placement agent.
- Accelmed now owns ~69.3% of common stock, becoming the controlling stockholder.
- Board authorized reverse stock split at ratio between 1:5 and 1:25 within six months.
- Appointed Accelmed Managing Partner Dr. Uri Geiger to the board, effective upon closing.
- Proceeds expected to extend cash runway for at least 12 months; funds operations and R&D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1452965/000119312523030400/0001193125-23-030400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1452965/000119312523030400/d433380d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-030400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer